Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 42, Issue 2, 2003, Pages 209-216

  Pearson, Deborah A ^a,e   Santos, Cynthia W ^a,e   Roache, John D ^c   Casat, Charles D ^d   Loveland, Katherine A ^a   Lachar, David ^a,e   Lane, David M ^b   Faria, Laura P ^a   Cleveland, Lynne A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b RICE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^d Levine Cancer Institute   (United States)

^e National Center for Health Statistics   (United States)

Author keywords

Attention deficit hyperactivity disorder; Behavior; Mental retardation; Methylphenidate

Indexed keywords

METHYLPHENIDATE; CENTRAL STIMULANT AGENT;

ANOREXIA; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILD BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; HUMAN; MENTAL DEFICIENCY; PARENTAL BEHAVIOR; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; RATING SCALE; SIDE EFFECT; SLEEP DISORDER; TEACHER; TREATMENT OUTCOME; DRUG ADMINISTRATION; FEMALE; MALE; QUESTIONNAIRE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MENTAL RETARDATION; METHYLPHENIDATE; QUESTIONNAIRES;

EID: 0037317720     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200302000-00015     Document Type: Article

References (45)

1. Aman MG, Kern RA, McGhee DE, Arnold LE (1993), Fenfluramine and methylphenidate in children with mental retardation and ADHD: clinical and side effects. J Am Acad Child Adolesc Psychiatry 32:851-859
2. Aman MG, Kern RA, Osborne P, Tumuluru R, Rojahn J, del Medico V (1997), Fenfluramine and methylphenidate in children with mental retardation and borderline IQ: clinical effects Am J Ment Retard 101:521-534
3. Aman MG, Marks RE, Turbott SH, Wilsher CP, Merry SN (1991), Clinical effects of methylphenidate and thioridazine in intellectually subaverage children. J Am Acad Child Adolesc Psychiatry 30:246-256
4. Aman MG, Pejeau C, Osborne P, Rojahn J, Handen B (1996), Four-year follow-up of children with low intelligence and ADHD. Res Dev Disabil 17:417-432
5. American Psychiatric Association (1987), Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised (DSM-III-R). Washington, DC: American Psychiatric Association
6. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association
7. Biederman J, Faraone SV, Weber W, Russell RL, Rater M, Park K (1997), Correspondence between DSM-III-R and DSM-IV attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36:1682-1687
8. Conners CK (1989), Conners' Rating Scales Manual. North Tonawanda, NY: Multi-Health Systems
9. Fee VE, Matson JL, Benavidez DA (1994), Attention deficit-hyperactivity disorder among mentally retarded children. Res Dev Disabil 15.67-79
10. Feldman H, Crumrine P, Handen BL, Alvin R, Teodori J ( 1989), Methylphenidate in children with seizures and attention-deficit disorder. Am J Dis Child 143:1081-1086
11. Gadow KD (1985), Prevalence and efficacy of stimulant drug use with mentally retarded children and youth. Psychopharmacol Bull 21:291-303
12. Gadow KD, Poling AG (1988), Pharmacotherapy and Mental Retardation. Boston: Little, Brown
13. Gan J, Cantwell DP (1982), Dosage effects of methylphenidate on paired associate learning: positive/negative placebo responders. J Am Acad Child Psychiatry 21:237-242
14. Gould MS, Wunsch-Hitzig R, Dohrenwend B (1981), Estimating the prevalence of childhood psychopathology: a critical review. J Am Acad Child Psychiatry 20:462-476
15. Hagerman RJ, Murphy MA, Wittenberger MD (1988), A controlled trial of stimulant medication in children with the fragile X syndrome. Am J Med Genet 30:377-393
16. Handen BL, Breaux AM, Gosling A, Ploof DL, Feldman H (1990), Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder. Pediatrics 86:922-930
17. Handen BL, Breaux AM, Janosky J, McAuliffe S, Feldman H, Gosling A (1992), Effects and noneffects of methylphenidate in children with mental retardation and ADHD. J Am Acad Child Adolesc Psychiatry 31:455-461
18. Handen BL, Feldman H, Gosling A, Breaux AM, McAuliffe S (1991), Adverse side effects of methylphenidate among mentally retarded children with ADHD. J Am Acad Child Adolesc Psychiatry 30:241-245
19. Handen BL, Feldman HM, Lurier A, Murray PJH (1999), Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD. J Am Acad Child Adolesc Psychiatry 38:805-812
20. Handen BL, Janosky J, McAuliffe S (1997), Long-term follow-up of children with mental retardation/borderline intellectual functioning and ADHD. J Abnorm Child Psychol 25:287-295
21. Handen BL, Janosky J, McAuliffe S, Breaux AM, Feldman H (1994), Prediction of response to methylphenidate among children with ADHD and mental retardation. J Am Acad Child Adolesc Psychiatry 33:1185-1193
22. Hollingshead AB (1975), Four Factor Index of Social Status New Haven, CT: Yale University Department of Sociology
23. Jensen PS, Hinshaw SP, Kraemer HC et al. (2001), ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 40:147-158
24. Marshburn EC, Aman MG (1992), Factor validity and norms for the Aberrant Behavior Checklist in a community sample of children with mental retardation. J Autism Dev Disord 22:357-373
25. MTA Cooperative Group (1999), A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactiviry disorder: the MTA Cooperative Group Multimodal Treatment Study of Children With ADHD. Arch Gen Psychiatry 56:1073-1086
26. Payton JB, Burkhart JE, Hersen M, Helsel WJ (1989), Treatment of ADDH in mentally retarded children: a preliminary study. J Am Acad Child Adolesc Psychiatry 28:761-767
27. Pearson DA, Lachar D, Loveland KA et al. (2000), Patterns of behavioral adjustment and maladjustment in mental retardation: a comparison of children with and without ADHD. Am J Ment Retard 105:236-251
28. Pearson DA, Santos CW, Roache JD et al. (1996a), Effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD: preliminary findings from a study in progress. J Dev Phys Disabil 8:313-333
29. Pearson DA, Yaffee LS, Loveland KA, Lewis KR (1996b), A comparison of sustained and selective attention in children who have mental retardation with and without attention deficit hyperactivity disorder. Am J Ment Retard 100:592-607
30. Pelham WE, Walker JL, Sturges J, Hoza J (1989), Comparative effects of methylphenidate on ADD girls and ADD boys. J Am Acad Child Adolesc Psychiatry 28:773-776
31. Physician's Desk Reference (1991), Oradell, NJ: Medical Economics Company
32. Power TJ, Blum NJ, Jones SM, Kaplan PE (1997), Brief report: response of methylphenidate in two children with Williams syndrome. J Autism Dev Disord 27:79-87
33. Quay HC, Peterson DR (1987), Manual for the Revised Behavior Problem Checklist. Available from HC Quay, Box 240074, U Miami, Coral Gables, FL 33124
34. Rapport MD, Stoner G, DuPaul GJ, Birmingham BK, Tucker S (1985), Methylphenidate in hyperactive children: differencial effects of dose on academic, learning, and social behavior. J Abnorm Child Psychol 13, 227-244
35. Reich W, Welner Z, Herjanic B (1991), Diagnostic Interview for Children and Adolescents-Revised. North Tonawanda, NY: Multi-Health Systems
36. Sleator EK, Sprague RL (1978), Pediatric psychopharmacology. In: Principles of Psychopharmacology, 2nd ed, Clark WG, del Giudice J, eds. New York: Academic Press, pp 573-591
37. Solanto MV, Conners CK (1982), A dose-response and time-action analysis of autonomic and behavioral effects of methylphenidate in attention deficit disorder with hyperactivity. Psychophysiology 19:658-667
38. Sprague RL, Sleator EK (1977), Methylphenidate in hyperkinetic children: differences in dose effects in learning in social behavior. Science 198:1274-1276
39. Thorndike RL, Hagen EP, Sattler JM (1986), Guide for Administering and Scoring the Stanford-Binet Intelligence Scale, 4th ed. Chicago: Riverside Publishing
40. Ullmann RK, Sleator EK (1985), Attention deficit disorder children with or without hyperactivity: which behaviors are helped by stimulants? Clin Pediatr (Phila) 24:547-551
41. Ullmann RK, Sleator EK, Sprague RL (1985), Introduction to the use of the ACTeRS Psychopharmacol Bull 21:915-920
42. Varley CK, Trupin EW (1982), Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder: a preliminary study. AmJ Ment Defic 86:560-566
43. Wagenarr WA (1969), Note on the construction of digram-balanced Latin squares. Psychol Bull 72:384-386
44. Wirt RD, Lachar D, Klinedinst JK, Seat D (1984), Multidimensional Description of Child Personality: A Manual for the Personality Inventory for Children, revised. Los Angeles: Western Psychological Services
45. Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A, Brown J (1996), Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry 35:319-324